Emerging influenza virus: A global threat

Journal of Biosciences

Volumn 33, Issue 4, 2008, Pages 475-482

  Khanna, M ^a   Kumar, P ^a   Choudhary, K ^a   Kumar, B ^a   Vijayan, V K ^b  

^a UNIVERSITY OF DELHI   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

H1N1; H3N2; H5N1; Influenza; Pandemic

Indexed keywords

AMANTADINE; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; LIVE VACCINE; OSELTAMIVIR; RIMANTADINE; STEROID; ZANAMIVIR;

CHILD HEALTH; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE TRANSMISSION; EPIDEMIOLOGY; INFLUENZA; INTERMEDIATE HOST; MORBIDITY; MORTALITY; VIRULENCE; VIRUS;

AVIAN INFLUENZA; DRUG MECHANISM; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS B; INFLUENZA VIRUS C; LABORATORY DIAGNOSIS; LOW DRUG DOSE; NONHUMAN; REVIEW; SEPTIC SHOCK; VIRULENCE; VIRUS MUTATION; VIRUS REPLICATION;

ANIMALS; BIRDS; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; HUMANS; INDIA; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; POPULATION SURVEILLANCE;

AVES; INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE;

EID: 58149174091     PISSN: 02505991     EISSN: 02505991     Source Type: Journal    
DOI: 10.1007/s12038-008-0066-z     Document Type: Review

References (58)

1. Y. Abed N. Goyette G. Boivin 2005 Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations Antimicrob. Agents Chemother. 49 556 559
2. D. Areechokchai C. Jiraphongsa Y. Laosiritaworn W. Hanshaoworakul M. O'Reilly 2006 Investigation of avian influenza (H5N1) outbreak in humans-Thailand, 2004 Morb. Mortal. Wkly Rep. 55 3 6
3. R. B. Belshe W. C. Gruber P. M. Mendelman H. B. Mehata K. Mahmood K. Reisinger J. Treanor K. Zangwill 2000 Correlates of imune protection induced by live, attenuated, cold adapted, trivalent, intranasal influenza virus vaccine J. Infect. Dis. 181 1133 1137
4. R. B. Belshe W. C. Gruber P. M. Mendelman I. Cho K. Reisinger S. L. Block J. Wittes D. Iacuzio 2000 Efficacy of vaccination with live atteuated, cold adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sidney) not contained in the vaccine J. Pediatr. 136 168 175
5. R. B. Belshe H. M. Smith C. B. Hall R. Betts A. J. Hay 1988 Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection J. Virol. 62 1508 1512
6. C. B. Bridges W. Lim J. Hu-Primmer L. Sims K. Fukuda K. H. Mak T. Rowe W. W. Thompson 2002 Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998 J. Infect. Dis. 185 1005 1010
7. B. G. Brumback C. D. Wade 1996 Simultaneous rapid culture for four respiratory viruses in the same cell monolayer using a differential multicolored fluorescent confirmatory stain J. Clin. Microbiol. 34 798
8. S. Call M. Vollenweider C. Hornung D. Simel W. McKinney 2005 Does this patient have influenza? JAMA 293 987
9. F. G. Davies J. Casals D. M. Jesset P. Ochieng 1978 The serological relationships of Nairobi sheep disease virus J. Comp. Pathol. 88 519
10. V. Demicheli T. Jefferson D. Rivet J. Deeks 2000 Prevention and early treatment of influenza in healthy adults Vaccine. 18 957 1030
11. P. N. Dinh H. T. Long N. T. Tien N. T. Hien 2006 Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004 Emerg. Infect. Dis. 12 1841 1847
12. P. A. Dunnil 2006 DNA flu vaccine in practice Nat. Biotechnol. 24 139
13. R. Eccles 2005 Understanding the symptoms of the common cold and influenza Lancet Infect. Dis. 5 718
14. L. R. Elveback J. P. Fox E. Ackerman 1976 An influenza simulation model for immunization studies Am. J. Epidemiology. 103 152
15. L. V. Gubareva J. A. McCullers R. C. Bethell R. G. Webster 1998 Characterization of influenza A/Hong Kong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice J. Infect. Dis. 178 1592
16. F. G. Hayden A. J. Hay 1992 Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine Curr. Top. Microbiol. Immunol. 176 119 130
17. M. Hilleman 2002 Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control Vaccine 20 3068 3087
18. G. K. Hirst 1941 Agglutination of red cells by amniotic fluid of chick embryos infected with influenza virus Science 94 22
19. E. Hoffmann K. Mahmood Z. Chen C.-F. Yang J. Spaete H. B. Greenberg M. L. Herlocher H. Jin G. Kemble 2005 Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/ 1/66 J. Virol. 79 11014 11021
20. D. C. Hui 2008 Influenza A/H5N1 infection: Other treatment options and issues Respirology 13 S22 S26
21. D. S. C. Hui 2008 Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection Respirology 13 S10 S13
22. H. Jin B. Lu H. Zhou C. Ma J. Zhao C. F. Yang G. Kenble H. Greenberg 2003 Multiple amino acid residues confer temperature sensitivity to influenza virus vaccine strains (FluMist) derived from cold adapted A/Ann Arbor/ 6/60 Virology 306 18 24
23. I. N. Kandun H. Wibisono E. R. Sedyaningsih Yusharmen W. Hadisoedarsuno W. Purba H. Santoso C. Septiawati 2006 Three Indonesian clusters of H5N1 virus infection in 2005 N. Engl. J. Med. 355 2186 2194
24. Y. Kawaoka S. Krauss R. G. Webster 1989 Avian to human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics J. Virol. 63 4603
25. H. Kaneko T. Kawana E. Fukushima T. Suzutani 2007 Tolerance of loop-mediated isothermal amplification to a culture medium and biological substances J. Biochem. Biophys. Methods 70 499
26. A. A. Kerr J. McQuillin M. A. Downham P. S. Gardner 1975 Gastric flu influenza B causing abdominal symptons in children Lancet 1 291
27. M. Khanna P. Kumar 2002 Influenza: A serious global threat J. Infect. Dis. Antimicro Agents 19 25
28. M. Khanna V. Srivastava 2006 Clinical laboratory diagnosis of influenza Adv. Med. Veter. Virol. Immunol. Epidemiol. 6 138
29. A. R. La Spada E. M. Wilson D. B. Lubahn A. E. Harding K. H. Fischbeck 1991 Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy Nature (London) 352 77
30. C. W. Lee D. L. Suarez 2004 Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus J. Virol. Methods 119 151
31. T. M. Mathew 2006 Epidemiology of influenza A, B and C Adv. Med. Veter. Virol. Immunol. Epidemiol. 6 24
32. J. McElhaney B. L. Beattie R. Devin R. Grynoch E. L. Toth R. C. Bleackely 1990 Age related decline in interleukin 2 production in response to influenza vaccine J. Am. Geriatr. Soc. 38 652 658
33. Ministry of Health. U K 1920 Report on the pandemic of influenza, 1918-19; Rep. Health Med. Subjects 4 182
34. A. S. Monto D. P. Robinson M. L. Herlocher J. M. Hinson M. J. Elliott A. Crisp 1999 Zanamivir in the prevention of influenza among healthy adults JAMA 282 31 35
35. S. J. Olsen K. Ungchusak L. Sovann T. M. Uyeki S. F. Dowell N. J. Cox W. Aldis S. Chunsuttiwat 2005 Family clustering of avian influenza A (H5N1) Emerg. Infect. Dis. 11 1799 801
36. I. Orskov F. Orskov 1990 Serologic classification of fimbriae Curr. Top. Microbiol. Immunol. 151 71
37. M. T. Osterholm 2005 Preparing for the next pandemic N. Engl. J. Med. 352 1839
38. P. Palese 2004 Influenza: Old and new threats Nat. Med. 10 S82
39. L. L. M. Poon C. S. W. Leung K. H. Chan J. H. C. Lee K. Y. Yuen Y. Guan J. S. M. Peiris 2005 Detection of human influenza A viruses by loop-mediated isothermal amplification J. Clin. Microbiol. 43 427
40. R. G. Ridley 2004 Research on infectious diseases requires better coordination Nat. Med. 10 S137
41. N. Schmitz M. Kurrer M. Bachmann M. Kopf 2005 Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection J. Virol. 79 6441
42. E. R. Sedyaningsih S. Isfandari V. Setiawaty L. Rifati S. Harun W. Purba P. J. Blair S. D. Putman 2007 Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006 J. Infect. Dis. 196 522 527
43. I. Stephenson K. G. Nicholson J. M. Wood M. C. Zambon J. M. Katz 2004 Confronting the avian influenza threat; vaccine development for a potential pandemic Lancet 4 499
44. J. Stockton J. S. Ellis M. Saville J. P. Clewley M. C. Zambon 1998 Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses J. Clin. Microbiol. 36 2990
45. P.A. Tambyah 2008 Update on influenza vaccines Respirology 13 S41 S43
46. L. D. Trani B. Bedini I. Donatelli L. Campitelli B. Chiappini M. A. Marco M. Delogu C. Buonavoglia G. Vaccari 2006 A sensitive one-step real-time PCR for detection of avian influenza viruses using a MGB probe and an internal positive control BMC Infect. Dis. 6 87
47. K. Ungchusak P. Auewarakul S.F. Dowell R. Kitphati W. Auwanit P. Puthaathana M. Uipraserkul K. Boonnak 2005 Probable person-to-person transmission of avian influenza A (H5N1) N. Engl. J. Med. 352 333 340
48. C. Wang K. Takeuchi L. H. Pinto R. A. Lamb 1993 Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block J. Virol. 67 5585
49. R. J. Webby R. G. Webster 2003 Are we ready for pandemic influenza? Science 302 1519
50. World Health Organization 2005 Avian influenza: Assessing the pandemic threat (Geneva)
51. World Health Organization 2007 Clinical management of human infection with avian influenza A (H5N1) virus. Updated advice 15 August available from http://www.who.int/csr/disease/avian_influenza/guidelines/ClinicalManagement07. pdf
52. World Health Organization 2006 Recommendations and laboratory procedures for detection of avian influenza A (H5N1) virus in specimens from suspected human cases. available from URL: http://www.who.int/csr/disease/avian_influenza/ guidelines/RecAIlabtestsAug07pdf
53. World Health Organization 2008 Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO - available from URL: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2008_01_11/ en/print.html
54. World Health Organization. Update 2007 WHO-confirmed human cases of avian influenza A (H5N1) infection Wkly. Epidemiol. Rec. 82 41 47
55. K. E. Wright G. A. R. Wilson D. Novosad C. Dimock D. Tan J. M. Weber 1995 Typing and subtyping of influenza viruses in clinical samples by PCR J. Clin. Microbiol. 33 1180 1184
56. Writing committee of the second World Health Organization 2008 Consultation on clinical aspects of human infection with avian influenza A (H5N1) virus. Update on avian influenza A (H5N1) virus infection in humans N. Engl. J. Med. 358 261 73
57. T. M. Uyeki 2008 Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses Respirology 13 S2 S9
58. H. Yu Z. Feng X. Zhang N. Xiang Y. Huai L. Zhou 2007 Human influenza A (H5N1) cases, urban areas of people's Republic of China, 2005-2006 Emerg. Infect. Dis. 13 1061 1065